Amniotechnology

Our products meet or exceed the Quality and donor testing expectations set by the FDA in 21 CFR 1271. Learn how we are different from every other manufacturer on the market. Our products are derived from amniotic tissues recovered under strict guidelines and policies without harming the mother or child. Amnio Technology was founded in 2012 and is focused on optimizing the regenerative potential and clinical use of amniotic tissue. PalinGen® products do not require fetal sacrifice and recovery is performed with maternal consent during elective Cesarean delivery. Manufacture of PalinGen® Membrane, Hydromembrane, XPlus Membrane, and XPlus Hydromembrane. Amnio Technology is committed to Compliance, Quality and fosters a culture of Continuous Improvement. All Amnio Technology Products are manufactured in an FDA Registered and American Association of Tissue Banks (AATB) accredited facility.